George Huntington Institut

George Huntington Institut

ghi

Contact Information

  Technology Park Munster, Johann-Krane Weg 27, 48149 Muenster, Germany

  +49 (251) 788-7880


Trials/Studies

LEGATOPrideHORIZONLogo

Site Coordinator

dornhege
Laura Dornhege 

unpictured_woman_orange
Paula Roulet 

Site Investigators


reilmann-sized
Ralf Reilmann, MD
Ralf is the founder of the George-Huntington-Institute and chair of the Huntington Unit at the Department of Neurology, University of Muenster, Germany. Ralf established one of the largest cohorts of symptomatic and premanifest HD gene carriers globally (currently ~500 participants in the REGISTRY observational study). Within the European Huntington’s Disease Network (EHDN), he served as elected member of the Executive Committee, Chair of the “Neuroprotective Therapy Working Group”, member of the “Clinical Trials Task Force”, and as Coordinating Global Principle Investigator of randomized multicenter multinational clinical trials. Ralf also serves as Chair of the “Motor Phenotype Working Group” of EHDN and established the EHDN UHDRS-TMS (Unified Huntington’s Disease Rating Scale – Total Motor Score) online certification for improved standardization of motor ratings, which is now required for all observational and clinical trials in HD. His main line of research focuses on the development of objective and quantitative motor (“Q-Motor”) outcome measures for clinical trials. Ralf trained at the University of Muenster (Germany) and at Columbia University (New York) and studied in Muenster, Paris, London, and New York.